1020104-56-6

Basic information

• Product Name: (R)-5-Bromo-thiophene-2-sulfonic acid (1-benzyloxy-2-oxo-2,3,4,7-tetrahydro-1H-azepin-3-yl)-amide
• Synonyms: (R)-5-Bromo-thiophene-2-sulfonic acid (1-benzyloxy-2-oxo-2,3,4,7-tetrahydro-1H-azepin-3-yl)-amide
• CAS NO: 1020104-56-6
• Molecular Weight: 457.369
• Mol File: 1020104-56-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (R)-5-Bromo-thiophene-2-sulfonic acid (1-benzyloxy-2-oxo-2,3,4,7-tetrahydro-1H-azepin-3-yl)-amide(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-5-Bromo-thiophene-2-sulfonic acid (1-benzyloxy-2-oxo-2,3,4,7-tetrahydro-1H-azepin-3-yl)-amide(1020104-56-6)
• EPA Substance Registry System: (R)-5-Bromo-thiophene-2-sulfonic acid (1-benzyloxy-2-oxo-2,3,4,7-tetrahydro-1H-azepin-3-yl)-amide(1020104-56-6)

Safety Data

• Hazardous Substances Data: 1020104-56-6(Hazardous Substances Data)

Upstream product

• 1020104-29-3 (+)-[1-(allyl-benzyloxy-carbamoyl)-but-3-(R)-enyl]-carbamic acid tert-butyl ester 
• 1020104-31-7 (-)-(1-benzyloxy-2-oxo-2,3,4,7-tetrahydro-1H-azepin-3-R-yl)-carbamic acid tert-butyl ester 
• 55854-46-1 5-bromo-2-thiophenesulfonyl chloride 
• 1020104-33-9 3-(R)-amino-1-benzyloxy-1,3,4,7-tetrahydro-azepin-2-one 
• 1020104-28-2 (-)-(1-benzyloxycarbamoyl-but-3-(R)-enyl)-carbamic acid tert-butyl ester 
• 622-33-3 N-benzyloxyamine 

Downstream Products

• 1020105-29-6 (-)-N-(1-hydroxy-2-oxo-2,3,4,7-tetrahydro-1H-azepin-3-yl)-5-p-tolylthiophene-2-sulfonamide 
• 1345691-70-4 C₁₆H₁₅ClN₂O₄S₂ 
• 1020104-54-4 5-(4-Methoxy-phenyl)-thiophene-2-sulfonic acid (1-hydroxy-2-oxo-2,3,4,7-tetrahydro-1H-azepin-3-(R)-yl)-amide 
• 1345691-71-5 C₂₂H₂₆ClN₃O₅S₂ 
• 1020105-28-5 C₂₃H₂₉N₃O₅S₂ 
• 1345691-72-6 C₂₅H₂₉N₃O₅S₂ 
• 1345691-78-2 C₂₄H₂₄N₂O₄S₂ 
• 1020104-55-5 (R)-5-(4-Methoxy-phenyl)-thiophene-2-sulfonic acid (1-benzyloxy-2-oxo-2,3,4,7-tetrahydro-1H-azepin-3-yl)-amide 

Relevant articles and documents

Discovery of novel cobactin-t based matrix metalloproteinase inhibitors via a ring closing metathesis strategy

The discovery of potent N-hydroxyl caprolactam matrix metalloproteinase (MMP) inhibitors (6) based on the natural product Cobactin-T (2) is described. The synthetic method, which utilizes the ring closing metathesis reaction, is compatible to provide comp